Chest
Airway Obstruction in Sarcoidosis: A Study of 123 Nonsmoking Black American Patients with Sarcoidosis
Section snippets
PATIENTS AND METHODS
One hundred twenty three black American nonsmoking patients with clinical, radiologic and histologic evidence of pulmonary sarcoidosis were consecutively selected from the sarcoidosis clinic at the Los Angeles County-University of Southern California Medical Center. Of 123 patients 109 (88 percent) had never smoked; 14 patients had infrequently smoked in the past but not during the five-year period preceding this study The sex and age distributions are shown in Table 1. The diagnosis of
METHODS
Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) and maximal voluntary ventilation (MVV) were measured with a 13-L Stead-Wells spirometer. A modification of the single-breath method (Forster) was used to measure diffusing capacity for carbon monoxide (DCO). Reference values for spirometry were those of Morris et al15 and Seltzer et al16 and a 13 percent reduction factor was used for those patients of African ancestry. The DCO and coefficient of diffusion (Kco)
RESULTS
The results of these studies are tabulated in Table 2, Table 3, Table 4.
COMMENT
In this study of 123 black nonsmokers with sarcoidosis, 78 (63 percent) were found to have reduced FEV1/FVC ratio. Thus, about two thirds of our patients on whom simple spirometry tests were done showed mild to severe airway obstruction. Although the incidence is considerably higher than is generally realized, it is consistent with the observation that sarcoidosis tends to be more extensive in black Americans, among whom it carries a poor prognosis.18, 19, 20, 21, 22, 23, 24, 25 Lung function
REFERENCES (32)
- et al.
Bronchostenosis due to sarcoidosis: a cause of atelectasis and airway obstruction simulating pulmonary neoplasm and chronic obstructive pulmonary disease
Chest
(1979) - et al.
Airway function in sarcoidosis
Am J Med
(1977) - et al.
Sarcoidosis: relationship between changes in lung structure and function
Am Rev Resp Dis
(1967) Studies on cardiopulmonary function in sarcoidosis
Acta Med Scand
(1961)Pulmonary function in sarcoidosis
- et al.
Exercise testing in the physiologic assessment of sarcoidosis
Ann NY Acad Sci
(1986) - et al.
Structure and function in sarcoidosis
Ann NY Acad Sci
(1976) - et al.
A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the John Hopkins Hospital and the Massachusetts General Hospital
Medicine
(1952) - et al.
Biopsy of the bronchial wall as an aid in diagnosis of sarcoidosis
JAMA
(1963) - et al.
Multiple bronchostenoses due to sarcoidosis: report of two cases
Brit Med J
(1957)
Pulmonary function in a case of endobronchial sarcoidosis
Am Rev Resp Dis
Airway function in chronic pulmonary sarcoidosis with fibrosis
Am Rev Resp Dis
Airway obstruction in pulmonary sarcoidosis
Bull Europ Physiopath Resp
Pulmonary function studies in patients with bilateral sarcoidosis of hilar lymph nodes
Arch Intern Med
Spirometric standards for healthy nonsmoking adults
Am Rev Resp Dis
Differences in pulmonary function related to smoking habits and race
Am Rev Resp Dis
Cited by (76)
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
2023, The Lancet Respiratory MedicineThe lung in autoimmune diseases: sarcoidosis
2022, Handbook of Systemic Autoimmune DiseasesSarcoidosis
2019, Medical Clinics of North AmericaCitation Excerpt :Pulmonary function testing is variable. It can be normal, restrictive, or obstructive.21 Diffusion capacity can also be impaired depending on the degree of pulmonary involvement.
Sarcoidosis
2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition
Manuscript received November 16; revision accepted January 21.